Please try another search
For the six months ended 30 September 2016, Rex Bionics PLC revenues increased 7% to L196K. Net loss increased 21% to L2.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Administrative Expenses increase of 22% to L3M (expense), Finance credit decrease from L113K (income) to L0K.
Period Ending: | Sep 30, 2016 | Mar 31, 2016 | Sep 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Revenue | 0.2 | 0.27 | 0.18 | -0.04 |
Gross Profit | 0.05 | 0.16 | -0.08 | |
Operating Income | -2.81 | -2.93 | -2.44 | -1.72 |
Net Income | -2.64 | -2.69 | -2.18 | -1.74 |
Period Ending: | Sep 30, 2016 | Mar 31, 2016 | Sep 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Total Assets | 15.7 | 15.78 | 18.16 | 19.1 |
Total Liabilities | 3.51 | 3.46 | 3.46 | 3.46 |
Total Equity | 12.19 | 12.32 | 14.7 | 15.65 |
Period Ending: | Sep 30, 2016 | Mar 31, 2016 | Sep 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 16 Months |
Cash From Operating Activities | -1.81 | -3.71 | -1.9 | -4.83 |
Cash From Investing Activities | -0.18 | -0.45 | -0.12 | -1.31 |
Cash From Financing Activities | 2 | 1.9 | 1.9 | 10.32 |
Net Change in Cash | 0.26 | -2.51 | -0.67 | 4.19 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review